Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Geron Corporation (NASDAQ:GERN) concerning possible violations of federal securities laws. Geron Corporation (NASDAQ:GERN) stock opened at $1.66 in last session, and closed at $1.69, while the day range of Geron Corporation (NASDAQ:GERN) stock is $1.39 – $1.82. The stock showed a positive weekly performance of -64.57%.
Anyone who was holding shares of Oxigene Inc. (NASDAQ:OXGN) when they woke up Wednesday morning no doubt was thrilled as the biotechnology firm’s stock more than doubled on test results for an ovarian cancer treatment. OXiGENE Inc. (NASDAQ:OXGN) stock opened at $5.28 in last session, and closed at $4.29 by gaining 77.27%. The 52 week range of $1.96 – $5.40. Company’s market capitalization is $11.33 million.
Shares of Zogenix Inc. (NASDAQ:ZGNX) fell as much as 26% on Wednesday after a rival pharmaceutical company said it will seek regulatory approval of a tamper-proof version of Zogenix’s powerful new pain drug. Zogenix, Inc. (NASDAQ:ZGNX) stock decreased -22.69% and finished the last session at $3.51. The EPS of the stock remained -0.44. Company’s market capitalization is $367.43 million.
Equities researchers at JMP Securities dropped their price target on shares of Synta Pharmaceuticals Corp. (NASDAQ:SNTA) from $14.00 to $10.00 in a research report issued on Wednesday, Stock Ratings Network reports. JMP Securities’ price target would indicate a potential upside of 119.78% from the company’s current price. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) stock opened the session at $4.62, and closed the session at $4.55. The 52 week range of the Synta Pharmaceuticals Corp. (NASDAQ:SNTA) stock remained $3.70 – $10.74 and the day range was $4.34 – $4.70.
Leave a Reply